These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30564869)
1. Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients. Arout CA; Waters AJ; MacLean RR; Compton P; Sofuoglu M Psychopharmacology (Berl); 2019 Oct; 236(10):2857-2866. PubMed ID: 30564869 [TBL] [Abstract][Full Text] [Related]
2. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain. Wachholtz A; Gonzalez G Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326 [TBL] [Abstract][Full Text] [Related]
3. Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone. Oaks Z; Stage A; Middleton B; Faraone S; Johnson B Discov Med; 2018 Nov; 26(144):197-206. PubMed ID: 30695679 [TBL] [Abstract][Full Text] [Related]
4. The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males. Tompkins DA; Smith MT; Bigelow GE; Moaddel R; Venkata SL; Strain EC Clin J Pain; 2014 Jan; 30(1):36-45. PubMed ID: 23446076 [TBL] [Abstract][Full Text] [Related]
5. Cannabinoid modulation of opioid analgesia and subjective drug effects in healthy humans. Babalonis S; Lofwall MR; Sloan PA; Nuzzo PA; Fanucchi LC; Walsh SL Psychopharmacology (Berl); 2019 Nov; 236(11):3341-3352. PubMed ID: 31201479 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment. Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486 [TBL] [Abstract][Full Text] [Related]
7. Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose. Athanasos P; Ling W; Bochner F; White JM; Somogyi AA Pain Med; 2019 Jan; 20(1):119-128. PubMed ID: 29514333 [TBL] [Abstract][Full Text] [Related]
8. Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models. Rowbotham MC; Wallace M J Pain; 2020; 21(9-10):1031-1046. PubMed ID: 32006699 [TBL] [Abstract][Full Text] [Related]
9. Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder. Schroeder JR; Phillips KA; Epstein DH; Jobes ML; Furnari MA; Kennedy AP; Heilig M; Preston KL Psychopharmacology (Berl); 2018 Oct; 235(10):2957-2966. PubMed ID: 30079432 [TBL] [Abstract][Full Text] [Related]
10. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial. Garland EL; Hanley AW; Kline A; Cooperman NA Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850 [TBL] [Abstract][Full Text] [Related]
11. The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment. Ellis JD; Han D; Mayo J; Hobelmann JG; Finan PH; Huhn AS Br J Clin Pharmacol; 2024 Jun; 90(6):1408-1417. PubMed ID: 38417973 [TBL] [Abstract][Full Text] [Related]
12. Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study. Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA Eur J Anaesthesiol; 2015 Apr; 32(4):248-54. PubMed ID: 24849503 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients. Compton PA; Ling W; Torrington MA Addict Biol; 2008 Sep; 13(3-4):393-402. PubMed ID: 18507735 [TBL] [Abstract][Full Text] [Related]
14. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain. Worley MJ; Heinzerling KG; Shoptaw S; Ling W Exp Clin Psychopharmacol; 2015 Dec; 23(6):428-35. PubMed ID: 26302337 [TBL] [Abstract][Full Text] [Related]
15. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia. Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941 [TBL] [Abstract][Full Text] [Related]
16. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Cooper ZD; Johnson KW; Vosburg SK; Sullivan MA; Manubay J; Martinez D; Jones JD; Saccone PA; Comer SD Drug Alcohol Depend; 2017 Sep; 178():340-347. PubMed ID: 28688296 [TBL] [Abstract][Full Text] [Related]
17. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. Hay JL; White JM; Bochner F; Somogyi AA; Semple TJ; Rounsefell B J Pain; 2009 Mar; 10(3):316-22. PubMed ID: 19101210 [TBL] [Abstract][Full Text] [Related]
18. Treatment of opioid dependence with buprenorphine/naloxone sublingual tablets: A phase 3 randomized, double-blind, placebo-controlled trial. Wang X; Jiang H; Zhao M; Li J; Gray F; Sheng L; Li Y; Li X; Ling W; Li W; Hao W Asia Pac Psychiatry; 2019 Mar; 11(1):e12344. PubMed ID: 30460781 [TBL] [Abstract][Full Text] [Related]
19. Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals. Huhn AS; Strain EC; Bigelow GE; Smith MT; Edwards RR; Tompkins DA Anesthesiology; 2019 Jan; 130(1):131-141. PubMed ID: 30418214 [TBL] [Abstract][Full Text] [Related]
20. Minocycline Prevents Muscular Pain Hypersensitivity and Cutaneous Allodynia Produced by Repeated Intramuscular Injections of Hypertonic Saline in Healthy Human Participants. Samour MS; Nagi SS; Shortland PJ; Mahns DA J Pain; 2017 Aug; 18(8):994-1005. PubMed ID: 28396046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]